Search research articles
Contact Us
Filters
Showing results (171-180 of 247) with videos related to
Page
of 25
Sort By:
International Journal of Antimicrobial Agents
|
October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii
Justin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model
Phillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
May 6, 2020
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model
Hajira Bilal, Phillip J Bergen, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy
|
October 26, 2011
Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine
Rebekah Henry, Nuwan Vithanage, Paul Harrison, et al.
Journal of Pharmaceutical Sciences
|
October 25, 2023
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula
Jürgen B Bulitta, Eunjeong Shin, Phillip J Bergen, et al.
Antimicrobial Agents and Chemotherapy
|
November 9, 2016
Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model
Cornelia B Landersdorfer, Tri-Hung Nguyen, Linh Thuy Lieu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2015
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Roger L Nation, Samira M Garonzik, Jian Li, et al.
Infectious Diseases and Therapy
|
December 10, 2015
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
Phillip J Bergen, Zackery P Bulman, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy
|
January 18, 2022
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling
Hajira Bilal, Jessica R Tait, Yinzhi Lang, et al.
The Journal of Antimicrobial Chemotherapy
|
May 16, 2017
Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli
Nicholas M Smith, Zackery P Bulman, Arthur O Sieron, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 247) with videos related to
Sort By:
Page
of 25
International Journal of Antimicrobial Agents
|
October 25, 2016
Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii
Justin R Lenhard, Jonathan S Gall, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
September 14, 2011
Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model
Phillip J Bergen, Brian T Tsuji, Jurgen B Bulitta, et al.
Antimicrobial Agents and Chemotherapy
|
May 6, 2020
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model
Hajira Bilal, Phillip J Bergen, Jessica R Tait, et al.
Antimicrobial Agents and Chemotherapy
|
October 26, 2011
Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine
Rebekah Henry, Nuwan Vithanage, Paul Harrison, et al.
Journal of Pharmaceutical Sciences
|
October 25, 2023
Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula
Jürgen B Bulitta, Eunjeong Shin, Phillip J Bergen, et al.
Antimicrobial Agents and Chemotherapy
|
November 9, 2016
Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model
Cornelia B Landersdorfer, Tri-Hung Nguyen, Linh Thuy Lieu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2015
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?
Roger L Nation, Samira M Garonzik, Jian Li, et al.
Infectious Diseases and Therapy
|
December 10, 2015
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria
Phillip J Bergen, Zackery P Bulman, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy
|
January 18, 2022
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling
Hajira Bilal, Jessica R Tait, Yinzhi Lang, et al.
The Journal of Antimicrobial Chemotherapy
|
May 16, 2017
Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coli
Nicholas M Smith, Zackery P Bulman, Arthur O Sieron, et al.
Page
of 25